Non-local impact of distal airway constrictions on patterns of inhaled particle deposition
- PMID: 39508002
- PMCID: PMC11539137
- DOI: 10.1098/rsos.241108
Non-local impact of distal airway constrictions on patterns of inhaled particle deposition
Abstract
Airway constriction and blockage in obstructive lung diseases cause ventilation heterogeneity and create barriers to effective drug deposition. Established computational particle-deposition models have not accounted for these impacts of disease. We present a new particle-deposition model that calculates ventilation based on the resistance of each airway, such that ventilation responds to airway constriction. The model incorporates distal airway constrictions representative of cystic fibrosis, allowing us to investigate the resulting impact on patterns of deposition. Unlike previous models, our model predicts how constrictions affect deposition in airways throughout the lungs, not just in the constricted airways. Deposition is reduced in airways directly distal and proximal to constrictions. When constrictions are clustered together, central-airways deposition can increase significantly in regions away from constrictions, but distal-airways deposition in those regions remains largely unchanged. We use our model to calculate lung clearance index (LCI), a clinical measure of ventilation heterogeneity, after applying constrictions of varying severities in one lobe. We find an increase in LCI coinciding with significantly reduced deposition in the affected lobe. Our results show how the model provides a framework for development of computational tools that capture the impacts of airway disease, which could significantly affect predictions of regional dosing.
Keywords: airway disease; cystic fibrosis; inhaled therapies; network modelling; particle deposition.
© 2024 The Authors.
Conflict of interest statement
We declare we have no competing interests.
Figures





Similar articles
-
Differences in Particle Deposition Between Members of Imaging-Based Asthma Clusters.J Aerosol Med Pulm Drug Deliv. 2019 Aug;32(4):213-223. doi: 10.1089/jamp.2018.1487. Epub 2019 Mar 19. J Aerosol Med Pulm Drug Deliv. 2019. PMID: 30888242 Free PMC article.
-
Substance deposition assessment in obstructed pulmonary system through numerical characterization of airflow and inhaled particles attributes.BMC Med Inform Decis Mak. 2017 Dec 20;17(Suppl 3):173. doi: 10.1186/s12911-017-0561-y. BMC Med Inform Decis Mak. 2017. PMID: 29297393 Free PMC article.
-
Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results.J Aerosol Med. 2004 Fall;17(3):239-48. doi: 10.1089/jam.2004.17.239. J Aerosol Med. 2004. PMID: 15625816
-
Current Needs Assessment for Using Lung Clearance Index for Asthma in Clinical Practice.Curr Allergy Asthma Rep. 2022 Feb;22(2):13-20. doi: 10.1007/s11882-022-01025-2. Epub 2022 Jan 24. Curr Allergy Asthma Rep. 2022. PMID: 35072930 Review.
-
Measuring Anatomical Distributions of Ventilation and Aerosol Deposition with PET-CT.J Aerosol Med Pulm Drug Deliv. 2023 Aug;36(4):210-227. doi: 10.1089/jamp.2023.29086.jgv. J Aerosol Med Pulm Drug Deliv. 2023. PMID: 37585546 Free PMC article. Review.
References
Associated data
LinkOut - more resources
Full Text Sources